He was spot on with my diagnosis, provided me with the proper medication, exact dosage, and I began to feel great the next morning
Se necessario, pu essere ulteriormente aumentata fino a un massimo di 1 mg una volta alla settimana
By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Whats next Glucagon-like peptide 1 (GLP-1) agonists, used to treat Type 2 diabetes and obesity, have been a success story in the industry, with Novo Nordisk riding a blockbuster wave with Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity, and Eli Lilly and Company also riding the wave with Mounjaro/Zepbound (tirzepatide), a dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 medication, respectively for treating Type 2 diabetes and obesity
This explains why many patients notice: Stronger appetite control on Wegovy Greater total weight loss Similar side effects, but sometimes more noticeable during dose increases This is not about stronger medication its about intentional dosing for a specific outcome
Clinical trials such as the STEP program (semaglutide) and SURMOUNT trials (tirzepatide) have demonstrated improvements in physical functioning and quality of life scores, which patients often interpret as increased energy
